Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

ImmunityBio (IBRX) Shares Issued: 2014-2024

Historic Shares Issued for ImmunityBio (IBRX) over the last 6 years, with Sep 2024 value amounting to $15.6 million.

  • ImmunityBio's Shares Issued was N/A to $15.6 million in Q3 2024 from the same period last year, while for Sep 2024 it was $82.4 million, marking a year-over-year change of. This contributed to the annual value of $73.3 million for FY2024, which is N/A change from last year.
  • Latest data reveals that ImmunityBio reported Shares Issued of $15.6 million as of Q3 2024, which was down 70.40% from $52.8 million recorded in Q2 2024.
  • Over the past 5 years, ImmunityBio's Shares Issued peaked at $93.9 million during Q2 2021, and registered a low of -$131.5 million during Q4 2021.
  • Its 3-year average for Shares Issued is $11.8 million, with a median of $126,000 in 2023.
  • In the last 5 years, ImmunityBio's Shares Issued plummeted by 93.40% in 2022 and then skyrocketed by 41,976.19% in 2024.
  • Over the past 5 years, ImmunityBio's Shares Issued (Quarterly) stood at $400,000 in 2020, then skyrocketed by 10,380.50% to -$131.5 million in 2021, then spiked by 99.94% to -$74,000 in 2022, then soared by 70.27% to -$126,000 in 2023, then surged by 41,976.19% to $15.6 million in 2024.
  • Its last three reported values are $15.6 million in Q3 2024, $52.8 million for Q2 2024, and $14.1 million during Q1 2024.